Coverage
Filings
| Filing | Date |
|---|---|
| Bavarian Nordic, financial calendar 2002 | 31 Jan 2002 |
| Bavarian Nordic, section 29 announcement from Nordea | 25 Jan 2002 |
| Bavarian Nordic, combine technologies with Epimmune | 29 Nov 2001 |
Bavarian Nordic's Chair of the Board, Luc Debruyne, has resigned with immediate effect, the Danish vaccine maker said, days after a takeover bid from a private equity consortium collapsed.
Bavarian Nordic's Chair of the Board, Luc Debruyne, has resigned with immediate effect, the Danish vaccine maker announced Thursday, days after a private equity takeover bid for the company collapsed.
A takeover offer for Danish vaccine maker Bavarian Nordic from a private equity consortium led by Nordic Capital and Permira has been withdrawn after failing to gain sufficient shareholder support.
A private equity consortium's takeover bid for Danish vaccine maker Bavarian Nordic is facing a crucial deadline, complicated by a major new European vaccine contract that could bolster the company's standalone value.
Bavarian Nordic has secured a new long-term contract to supply the European Union with up to 8 million doses of its smallpox and mpox vaccine over the next four years, the company said Friday.
A private equity consortium led by Nordic Capital and Permira has lowered the minimum shareholder acceptance threshold for its takeover offer for Danish vaccine maker Bavarian Nordic, as it struggles to win enough support for the deal.